These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9814011)

  • 1. [Secondary prevention is of significance for prognosis in coronary disease].
    de Faire U
    Lakartidningen; 1998 Oct; 95(42):4588-90, 4593-4. PubMed ID: 9814011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention and prevention of myocardial infarction.
    Pais PS
    J Hypertens Suppl; 2006 Apr; 24(2):S25-30. PubMed ID: 16601557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications.
    Chiuve SE; McCullough ML; Sacks FM; Rimm EB
    Circulation; 2006 Jul; 114(2):160-7. PubMed ID: 16818808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International trends in mortality and morbidity from ischaemic heart disease.
    Epstein FH
    Ann Clin Res; 1988; 20(1-2):21-5. PubMed ID: 3408209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(15):18, 20. PubMed ID: 15104261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary prophylaxis after myocardial infarction, bypass surgery and percutaneous coronary intervention].
    Eritsland J; Arnesen H
    Tidsskr Nor Laegeforen; 2004 Apr; 124(7):946-9. PubMed ID: 15060643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prophylaxis in general practice for patients with ischemic heart disease].
    Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J
    Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention after myocardial infarction].
    Vacheron A; Bounhoure JP;
    Bull Acad Natl Med; 2007 Nov; 191(8):1763-77. PubMed ID: 18666472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of secondary prevention in congestive heart failure due to coronary artery disease.
    Brook RD; Greenland P
    Coron Artery Dis; 1998; 9(10):653-8. PubMed ID: 9894617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerised systematic secondary prevention in ischaemic heart disease: a study in one practice.
    Starkey C; Michaelis J; de Lusignan S
    Public Health; 2000 May; 114(3):169-75. PubMed ID: 10878743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention.
    Behar S
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S41-3. PubMed ID: 10070817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.